WallStSmart
TNXP

Tonix Pharmaceuticals Holding Corp

NASDAQ: TNXP · HEALTHCARE · BIOTECHNOLOGY

$12.93
+4.27% today

Updated 2026-04-30

Market cap
$183.68M
P/E ratio
P/S ratio
14.01x
EPS (TTM)
$-14.57
Dividend yield
52W range
$12 – $70
Volume
0.4M

Tonix Pharmaceuticals Holding Corp (TNXP) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20082009201020112012201320142015201620172018201920202021202220232024
Total assets$45909.00$13031.00$4624.00$425446.00$2.12M$8.74M$39.54M$47.02M$27.51M$26.75M$26.32M$14.56M$98.18M$240.90M$225.69M$154.46M$162.89M
Cash & equivalents$40475.00$12606.00$4624.00$41123.00$1.79M$8.20M$38.18M$19.18M$18.94M$25.50M$25.03M$11.25M$77.07M$178.66M$120.23M$24.95M$98.78M
Current assets$45909.00$13031.00$4624.00$143553.00$2.01M$8.63M$39.04M$46.36M$27.14M$26.44M$26.06M$13.95M$87.99M$189.05M$130.78M$47.77M$119.00M
Total liabilities$3000.00$988.00$10305.00$2.88M$1.16M$2.22M$3.45M$6.76M$2.15M$2.14M$2.65M$5.14M$10.54M$22.18M$18.51M$48.93M$23.33M
Current liabilities$3000.00$988.00$10305.00$925276.00$1.14M$2.21M$3.38M$6.65M$2.12M$2.13M$2.65M$5.13M$9.82M$21.72M$18.18M$18.88M$18.31M
Long-term debt$1.93M$0.00$0.00$0.00$0.00$0.00$0.00$6.56M$4.67M
Shareholder equity$42909.00$12043.00$-5681.00$-2.45M$958708.00$6.51M$36.09M$40.26M$25.36M$24.62M$23.66M$9.42M$87.65M$218.72M$207.18M$105.53M$139.56M
Retained earnings$-22091.00$-52957.00$-70681.00$-6.39M$-15.84M$-26.73M$-54.34M$-102.40M$-141.24M$-162.36M$-188.45M$-217.07M$-267.53M$-359.82M$-470.04M$-600.66M$-730.69M
Accounts receivable$552.00$519000.00$2.83M$392000.00$494000.00$525000.00$1.01M$7.63M$7.73M$8.04M$4.59M$7.90M
Inventory$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.01M$-7.63M$-8.04M$14.15M$8.41M
Goodwill$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$965000.00$0.00